Anders Nobin

5.6k total citations
94 papers, 4.5k citations indexed

About

Anders Nobin is a scholar working on Cellular and Molecular Neuroscience, Neurology and Epidemiology. According to data from OpenAlex, Anders Nobin has authored 94 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Cellular and Molecular Neuroscience, 28 papers in Neurology and 27 papers in Epidemiology. Recurrent topics in Anders Nobin's work include Neuroendocrine Tumor Research Advances (26 papers), Neuroblastoma Research and Treatments (18 papers) and Neuroscience and Neuropharmacology Research (15 papers). Anders Nobin is often cited by papers focused on Neuroendocrine Tumor Research Advances (26 papers), Neuroblastoma Research and Treatments (18 papers) and Neuroscience and Neuropharmacology Research (15 papers). Anders Nobin collaborates with scholars based in Sweden, Germany and United States. Anders Nobin's co-authors include Anders Björklund, Ulf Stenevi, Olle Lindvall, Anders Bjo ̈rklund, L. Lachenmayer, A. Bj�rklund, Baumgarten Hg, H. G. Baumgarten, Robert Y. Moore and H. Mårtensson and has published in prestigious journals such as Cancer, The Journal of Comparative Neurology and Annals of Neurology.

In The Last Decade

Anders Nobin

94 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders Nobin Sweden 33 2.3k 1.1k 755 691 655 94 4.5k
Ch. Owman Sweden 44 2.9k 1.3× 1.8k 1.6× 759 1.0× 737 1.1× 1.1k 1.7× 156 6.1k
W. Feniuk United Kingdom 40 2.3k 1.0× 2.4k 2.1× 311 0.4× 394 0.6× 1.9k 2.9× 100 6.0k
Philip E. Duffy United States 35 3.7k 1.6× 2.5k 2.2× 919 1.2× 220 0.3× 636 1.0× 68 6.4k
Richard D. Broadwell United States 34 1.6k 0.7× 1.3k 1.1× 367 0.5× 539 0.8× 801 1.2× 54 4.7k
Tong H. Joh United States 41 2.1k 0.9× 1.7k 1.5× 523 0.7× 451 0.7× 568 0.9× 82 4.4k
Toshihiro Maeda Japan 39 2.7k 1.2× 2.1k 1.9× 395 0.5× 496 0.7× 648 1.0× 204 5.8k
F. Lembeck Austria 40 3.7k 1.6× 2.4k 2.1× 270 0.4× 399 0.6× 2.2k 3.3× 188 6.0k
Anne‐Marie O’Carroll United Kingdom 29 1.4k 0.6× 1.2k 1.1× 292 0.4× 684 1.0× 324 0.5× 50 4.5k
David Wynick United Kingdom 39 2.8k 1.2× 2.0k 1.8× 290 0.4× 540 0.8× 834 1.3× 96 4.2k
Toshihiro Suda Japan 43 1.2k 0.5× 940 0.8× 478 0.6× 1.1k 1.6× 835 1.3× 208 6.1k

Countries citing papers authored by Anders Nobin

Since Specialization
Citations

This map shows the geographic impact of Anders Nobin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Nobin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Nobin more than expected).

Fields of papers citing papers by Anders Nobin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Nobin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Nobin. The network helps show where Anders Nobin may publish in the future.

Co-authorship network of co-authors of Anders Nobin

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Nobin. A scholar is included among the top collaborators of Anders Nobin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Nobin. Anders Nobin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alexander, Barry, Mohammed Aslam, Anders Nobin, & I S Benjamin. (1998). Differentiation Between the Effects of Unprocessed Portal Blood and Reduced Liver Function on Brain Indole Amine Metabolism in the Portacaval Shunted Rat. Metabolic Brain Disease. 13(2). 137–146. 9 indexed citations
2.
Bengtsson, F., et al.. (1989). Serotonin Receptors in the Brain following Total Hepatectomy in Rats Treated with Branched‐Chain Amino Acids. Journal of Parenteral and Enteral Nutrition. 13(3). 235–239. 4 indexed citations
3.
Nobin, Anders, et al.. (1989). Evaluation of Temporary Liver Dearterialization and Embolization in Patients with Metastatic Carcinoid Tumour. Acta Oncologica. 28(3). 419–424. 25 indexed citations
4.
Nobin, Anders, et al.. (1989). Interferon Treatment in Patients with Malignant Carcinoids. Acta Oncologica. 28(3). 445–449. 28 indexed citations
5.
Nobin, Anders, Christer Owman, & Birgitta Arneklo-Nobin. (1987). Neuronal messengers in vascular function : focus on peripheral interaction between neuropeptides and classical transmitters. Elsevier eBooks. 3 indexed citations
6.
Lindvall, Olle, Erik‐Olof Backlund, Lars Farde, et al.. (1987). Transplantation in Parkinson's disease: Two cases of adrenal medullary grafts to the putamen. Annals of Neurology. 22(4). 457–468. 198 indexed citations
7.
Bengtsson, F., et al.. (1987). The effect of blood ingestion on brain serotonin synthesis in portacaval-shunted rats. Research in Experimental Medicine. 187(5). 353–358. 4 indexed citations
8.
Nobin, Anders, K Erhardt, Gert Auer, Sture Falkmer, & H. Mårtensson. (1987). Nuclear DNA patterns and survival in metastasizing ileal carcinoids. World Journal of Surgery. 11(3). 372–377. 8 indexed citations
9.
Törnebrandt, K., J Eskilsson, & Anders Nobin. (1986). Heart involvement in metastatic carcinoid disease. Clinical Cardiology. 9(1). 13–19. 24 indexed citations
10.
Falkmer, Sture, K Erhardt, Gert Auer, H. Mårtensson, & Anders Nobin. (1986). Patterns of DNA Distribution and Neurohormone Immunoreactivity in the Tumour Cells: Tools for the Histopathological Assessment of Gastro-Intestinal Carcinoids. Digestion. 35(1). 144–152. 8 indexed citations
11.
Nobin, Anders, et al.. (1985). Increased Levels of Plasma 5-Hydroxytryptamine in Patients with Coeliac Disease. Scandinavian Journal of Gastroenterology. 20(3). 304–308. 20 indexed citations
12.
Nobin, Anders, et al.. (1984). Pancreatic polypeptide-producing tumors report on two cases. Cancer. 53(12). 2688–2691. 17 indexed citations
13.
Simert, G., Anders Nobin, E. Rosengren, & J Vang. (1978). Neurotransmittor Changes in the Rat Brain after Portacaval Anastomosis. European Surgical Research. 10(2). 73–85. 25 indexed citations
14.
Nobin, Anders, B. Falck, Stig Ingemansson, Johannes Järhult, & E. Rosengren. (1977). Organization and function of the sympathetic innervation.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 452. 103–6. 39 indexed citations
15.
Hg, Baumgarten, et al.. (1975). Neurotoxicity of hydroxylated tryptamines: structure-activity relationships. 1. Long-term effects on monoamine content and fluorescence morphology of central monoamine neurons.. PubMed. 429. 5–27. 20 indexed citations
16.
Björklund, Anders, et al.. (1975). Neurotoxicity of hydroxylated tryptamines: structure-activity relationships. 2. In vitro studies on monoamine uptake inhibition and uptake impairment.. PubMed. 429. 29–60. 21 indexed citations
17.
H�kanson, R., F. Sundler, Anders Nobin, et al.. (1974). Peptides with NH2-terminal tryptophan in the adenohypophysis. Cell and Tissue Research. 150(2). 281–90. 17 indexed citations
18.
Nobin, Anders, et al.. (1973). The pars intermedia of the mink, Mustela vison. Cell and Tissue Research. 143(3). 313–327. 15 indexed citations
19.
Baumgarten, H. G., A. Bj�rklund, A. F. Holstein, & Anders Nobin. (1972). Organization and ultrastructural identification of the catecholamine nerve terminals in the neural lobe and pars intermedia of the rat pituitary. Cell and Tissue Research. 126(4). 483–517. 194 indexed citations
20.
Hg, Baumgarten, Anders Björklund, L. Lachenmayer, Anders Nobin, & Ulf Stenevi. (1971). Long-lasting selective depletion of brain serotonin by 5,6-dihydroxytryptamine.. PubMed. 373. 1–15. 201 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ch. Owman Breakdown of academic impact, for papers by W. Feniuk Breakdown of academic impact, for papers by Philip E. Duffy Breakdown of academic impact, for papers by Richard D. Broadwell Breakdown of academic impact, for papers by Tong H. Joh Breakdown of academic impact, for papers by Toshihiro Maeda Breakdown of academic impact, for papers by F. Lembeck Breakdown of academic impact, for papers by Anne‐Marie O’Carroll Breakdown of academic impact, for papers by David Wynick Breakdown of academic impact, for papers by Toshihiro Suda
Rankless by CCL
2026